HCP and Patient Targeting

Accurately Identify Patients and Their HCPs, Even for Rare and Hard-to-Diagnose Conditions

MMIT’s HCP and Patient Targeting Solution is powered by NorstellaLinQ, the industry’s first and only fully integrated data asset created by MMIT’s parent company Norstella.

Using structured and unstructured data like electronic medical records, open and closed claims, and lab orders and results, we help you pinpoint hard-to-reach patients and their treating providers.

Learn More


Patient Finding

Identify patients and their treating providers at the right time in the patient journey.

Market Sizing

Understand the true prevalence of rare and hard-to-diagnose conditions.

Risk Stratification

Hyper-segment patients using clinical notes, lab results and other real-world data.

Patient Journey

Correlate treatment patterns with HCP sentiment and behavior, payer coverage, site-of-care trends and other factors.

Feature

How We Can Help

rwd-insights-how-we-help
green-arrow
green-arrow

Our tech, data, clinical, and pharma experts tailor the data to your needs to ensure success.

green-arrow

Our harmonized, linked, longitudinal data is ready to use.

green-arrow

Outputs can be delivered in a tailored solution that meets your needs.

Slide 3

WHATS NEW

Keep Up-to-Date With Key Insights From MMIT

norstellalinq

NorstellaLinQ

The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in commercialization.

unlocking-value-potential-for-a-clients-rare-disease-treatment

Unlocking Value Potential for a Client’s Rare Disease Treatment

Learn how MMIT, powered by NorstellaLinQ, translated complex real-world data into actionable strategies to help a pharmaceutical manufacturer identify patients early in the treatment journey for a rare disease.

complex-cohort-identification-fuels-real-time-hcp-targeting

Complex Cohort Identification Fuels Real-Time HCP Targeting

Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
rwd-visualizations

RWD Visualizations

MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.

rwd-insights

RWD Insights

Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.

unstructured-data

Unstructured Data

MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.